ArticleCureus2024

Efficacy of Enfortumab Vedotin After Chemotherapy With Anti-programmed Death-Ligand 1 (PD-L1) Maintenance Treatment in a Clear Cell Variant of Invasive Urothelial Carcinoma of the Renal Pelvis: A Case Report.

Hiroshi Hirata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.